1. Home
  2. GMRE vs AURA Comparison

GMRE vs AURA Comparison

Compare GMRE & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMRE
  • AURA
  • Stock Information
  • Founded
  • GMRE 2011
  • AURA 2007
  • Country
  • GMRE United States
  • AURA United States
  • Employees
  • GMRE N/A
  • AURA N/A
  • Industry
  • GMRE Real Estate Investment Trusts
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GMRE Real Estate
  • AURA Health Care
  • Exchange
  • GMRE Nasdaq
  • AURA Nasdaq
  • Market Cap
  • GMRE 446.7M
  • AURA 396.8M
  • IPO Year
  • GMRE N/A
  • AURA 2021
  • Fundamental
  • Price
  • GMRE $7.33
  • AURA $6.55
  • Analyst Decision
  • GMRE Buy
  • AURA Strong Buy
  • Analyst Count
  • GMRE 3
  • AURA 7
  • Target Price
  • GMRE $10.38
  • AURA $22.29
  • AVG Volume (30 Days)
  • GMRE 671.1K
  • AURA 156.0K
  • Earning Date
  • GMRE 08-05-2025
  • AURA 08-13-2025
  • Dividend Yield
  • GMRE 8.19%
  • AURA N/A
  • EPS Growth
  • GMRE N/A
  • AURA N/A
  • EPS
  • GMRE 0.07
  • AURA N/A
  • Revenue
  • GMRE $141,896,000.00
  • AURA N/A
  • Revenue This Year
  • GMRE $4.47
  • AURA N/A
  • Revenue Next Year
  • GMRE $3.60
  • AURA N/A
  • P/E Ratio
  • GMRE $109.16
  • AURA N/A
  • Revenue Growth
  • GMRE 2.95
  • AURA N/A
  • 52 Week Low
  • GMRE $6.06
  • AURA $4.35
  • 52 Week High
  • GMRE $10.46
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • GMRE 64.70
  • AURA 47.00
  • Support Level
  • GMRE $6.94
  • AURA $6.10
  • Resistance Level
  • GMRE $7.14
  • AURA $7.40
  • Average True Range (ATR)
  • GMRE 0.27
  • AURA 0.38
  • MACD
  • GMRE 0.06
  • AURA -0.06
  • Stochastic Oscillator
  • GMRE 97.27
  • AURA 34.62

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: